2024

  • Dodel M, Guiducci G, Dermit M, Krishnamurthy S, Award EL, Capraro F, Rekad Z, STOJIC L and Mardakheh FK. TREX reveals proteins that bind to specific RNA regions in living cells. Nature Methods (2024)

2023

  • Dodel M, Guiducci G, Dermit M, Krishnamurthy S, STOJIC L and Mardakheh FK. TREX reveals proteins that bind to specific RNA regions in living cells, BioRxiv (2023).

  • Camera F, Romero-Camarero I, Revell BH, Amaral FMR, Sinclair OJ, Simeoni F,  Wiseman DH, STOJIC L and Somervaille TCP. Differentiation block in acute myeloid leukemia regulated by intronic sequences of FTO. iScience (2023). 

2022

  • Søndergaard JN, Sommerauer C, Atanasoai I, Hinte LC, Geng K, Guiducci G, Bräutigam L, Aouadi M, STOJIC L, Barragan I and Kutter C. CCT3-LINC00326 axis regulates hepatocarcinogenic lipid metabolism. Gut (2022).

2021

  • Guiducci G and STOJIC L. Long Noncoding RNAs at the Crossroads of Cell Cycle and Genome Integrity. Trends in Genetics (2021).

2020

  • STOJIC L, Lun ATL, Mascalchi P, Ernst C, Redmond AM, Mangei J, Barr A, Bousgouni V, Bakal C, Marioni JC, Odom DT and Gergely F. A high-content RNAi screen reveals multiple roles for long noncoding RNAs in cell division. Nature Communications (2020).

2018

  • STOJIC L, Lun ATL, Mangei J, Mascalchi P, Quarantotti V, Barr A, Bakal C, Marioni JC, Gergely F and Odom DT. Specificity of RNAi, LNA and CRISPRi as loss-of-function methods in transcriptional analysis. Nucleic Acids Res (2018).
  • Tichon A, Ben-Tov Perry R, STOJIC L and Ulitsky I. SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA. Genes & Development (2018).

2017

  • Chavali PL, STOJIC L, Meredith LW, Nahorski MS, Bayliss R, Marcelis CL, Goodfellow I, Woods GC and Gergely F. The neural RNA-binding protein Musashi 1 regulates human brain size and drives Zika virus replication. Science (2017). Highlighted in Science, Nature Reviews Neurology and Cell Host & Microbe.
  • Martinez-Jimenez CP, Niels E, Chen HG, Vallejos CA, Kolodziejczyk AA, Connor F, STOJIC L, Rayner TF, Stubbington, Teichmann ST, de la Roche M, Marioni JC and Odom DT. Aging increases cell-to-cell transcriptional variability upon immune stimulation. Science (2017).

2016

  • STOJIC L, Niemczyk M, Orjalo A, Ito Y, Ruijter AM, Uribe-Lewis S, Joseph N, Weston S, Menon S, Odom DT, Rinn J, Gergely F, Murrell A. Transcriptional silencing of long noncoding RNA GNG12-AS1 uncouples its transcription and product-related function. Nature Communications (2016).
  • Ernst C, Pike J, Aitken SJ, Long HK, Eling N, STOJIC L, Ward MC, Connor F, Rayner TF, Lukk M1 Klose RJ, Kutter C, Odom DT. Successful transmission and transcriptional deployment of a human chromosome via mouse male meiosis. Elife (2016).

2015

  • Uribe-Lewis S, Stark R, Carroll T, Dunning MJ, Bachman M, Delatte B Defrance M, Menon S, Halim S, Vowler S, Parashar D, Silva AL, Ten- Hoopen R, Ito Y, STOJIC L, Krueger F, Buczacki SJA, Winton DJ, Brenton JD, Ibrahim AEK, Fuks F, Murrell A. 5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer. Genome Biology (2015).

2013

  • Niemczyk M, Ito Y, Huddleston J, Git A, Caldas C, STOJIC L, Murrell A. Imprinted chromatin around DIRAS3 regulates alternative splicing of GNG12-AS1, a long non-coding RNA. Am J Hum Genet (2013).

2011

  • Uribe-Lewis S, Woodfine K, STOJIC L, Murrell A. Molecular mechanisms of genomic imprinting and clinical implications for cancer. Expert Rev Mol Med (2011).
  • STOJIC L, Jasencakova Z, Prezioso C, Stutzer A, Bodega B, Pasini D, Klingberg R, Mozzetta C, Margueron R, Puri PL, Schwarzer D, Helin K, Fischle W, Orlando V. Chromatin regulated interchange between PRC2-Ezh2 and PRC2-Ezh1 complexes controls Myogenin activation in skeletal muscle cells. Epigenetics & Chromatin (2011).
  • Borbone E, Troncone G, Ferraro A, Jasencakova Z, STOJIC L, Esposito F, Hornig N, Fusco A, Orlando V. EZH2 overexpression has a role in the development of anaplastic thyroid carcinomas. J Clin Endocrinol Metab (2011).

2007

  • Pani E, STOJIC L, El-Shemerly M, Jiricny J, Ferrari S. Mismatch Repair Status and the Response of Human Cells to Cisplatin. Cell Cycle (2007).

2005

  • STOJIC L, Cejka P, Jiricny J. High doses of SN1 type methylating agents activate DNA damage signalling cascades that are largely independent of mismatch repair. Cell Cycle (2005).

2004

  • STOJIC L, Mojas N, Cejka P, di Pietro M, Ferrari S, Marra G, Jiricny J. Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase. Genes & Development (2004).
  • STOJIC L, Brun R, Jiricny J. Mismatch repair and DNA damage signaling. DNA Repair (2004).
  • Cejka P, STOJIC L, Marra G, Jiricny J. Is mismatch repair really required for ionizing radiation-induced DNA damage signaling? Nature Genetics (2004).

2003

  • Cejka P, STOJIC L, Mojas N, Russell AM, Heinimann K, Cannavo E, di Pietro M, Marra G, Jiricny J. Methylation induced G2/M arrest requires a full complement of the mismatch repair protein hMLH1. EMBO J (2003).
  • Di Pietro M, Marra G, Cejka P, STOJIC L, Menigatti M, Cataruzza MS, Jiricny J. Mismatch repair dependent transcriptome changes in human cells treated with the methylating agent MNNG. Cancer Res (2003).